Global Companion Diagnostics Market - Industry Trends and Forecast to 2026

  • Diagnostic Imaging
  • Upcoming Report
  • Sep 2019
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Companion Diagnostics Market By Product and Services (Assay Kits and Reagents, Software & Services), Technology (Polymerase Chain Reaction, Molecular Diagnostics, FISH, CISH, Immunohistochemistry, Real-time PCR,  Next-Generation Sequencing, Gene Sequencing, In Situ Hybridization), Application (Colorectal Cancer, Breast Cancer, Lung Cancer, Melanoma, Urology, Gastric Cancer), Indication (Oncology {Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma} Neurology, Infectious Diseases), End Users (Pharmaceutical and Biopharmaceutical Companies, Reference Laboratories), Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa)– Industry Trends and Forecast to 2026 - Industry Trends and Forecast to 2026

Market Analysis: Global Companion Diagnostics Market

The global companion diagnostics market is growing at a healthy CAGR of 22.50% during the forecast period of 2019 to 2026. The report contains data of the base year 2018 and historic year 2017. The growth in the market is attributed to the rising of chronic diseases, growing demand for personalized medicine and growing adoption of companion diagnostics.

Market Definition: Global Companion Diagnostics Market

A companion diagnostic is a medical device, used as in- vitro device, which gives information about safety and effectiveness of drug. This is a kind of test which can help a healthcare professional to determine the beneficial effect of therapeutic products, and in analyzing the serious side effects and risks. Increasing number of genetic testing is enhancing the market growth.

Market Drivers

  • Increasing number of genetic testing is enhancing the market growth
  • Improvements in regulatory guidelines drive the market growth
  • Growing need for targeted therapies is flourishing the market growth
  • Rising cancer incidence worldwide acts as a catalyst for the market growth

Market Restraints

  • Increase in cost related to technological advancement is hampering the market growth
  • Reimbursement issues among many countries is restraining the market

Segmentation: Global Companion Diagnostics Market

By Product and Services

  • Assay Kits
  • Reagents
  • Software & Services

By Technology

  • Polymerase Chain Reaction
  • Molecular Diagnostics
  • FISH
  • CISH
  • Immunohistochemistry
  • In-situ Hybridization
  • Real-time PCR
  • Gene Sequencing
  • Next-Generation Sequencing

By Application

  • Colorectal Cancer
  • Breast Cancer
  • Lung Cancer
  • Melanoma
  • Urology
  • Gastric Cancer

By Indication

  • Oncology

    • Breast Cancer
    • Lung Cancer
    • Colorectal Cancer
    • Gastric Cancer
    •  Melanoma

  • Neurology
  • Infectious Diseases

By End Users

  • Pharmaceutical
  • Biopharmaceutical Companies
  • Reference Laboratories
  • Distribution Channel

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • Europe

    • Germany
    • Italy
    • U.K.
    • France
    • Spain
    • Netherlands
    • Belgium
    • Switzerland
    • Turkey
    • Russia
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific

  • South America

    • Brazil
    • Rest of South America

  • Middle East and Africa

    • South Africa
    • Rest of Middle East & Africa

Key Developments in the Market:

  • In May 2019, QIAGEN received approval on Piqray and fulvestrant combination, which helped to diagnose cancer in the patient. After this approval, Lab corp collaborated with QIAGEN, and broadened QIAGEN market share.
  • In June 2019, Agilent Technologies Inc. received the allowance of FDA on PD-L1 IHC 22C3 pharmDx. This allowance will aid to HNSCC patients for therapy with KEYTRUDA. This approval will expand its use and connect to more patients which will increase company’s revenue.

Competitive Analysis:

Global companion diagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of companion diagnostics market for global Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Some of the major players operating in global companion diagnostics market are F. Hoffmann-La Roche Ltd., Qiagen, Abbott, Almac Group, Agilent Technologies, Inc., Clinical Lab Products, Myriad Genetics, Inc., Leica Biosystems Nussloch GmbH, Resonance Health, ARUP Laboratories, Life Technologies Tm, Sysmex Corporation, Thermo Fisher Scientific Inc., Illumina, Inc., Hologic, Inc., Abnova Corporation, bioMérieux SA, Siemens Healthcare Private Limited  among others.

Research Methodology- Global Companion Diagnostics Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technical Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global companion diagnostics market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE